By Tyler Durden | 1 December 2020
ZERO HEDGE — With Moderna officially filing for expedited approval from the FDA yesterday, and Pfizer following up by announcing early Tuesday in the New York morning, With vaccine newsflow driving trading activity for yet another week, the team of analysts at Goldman Sachs has produced another handy guide to new developments in the race for a global vaccine.
Like the last update, Goldman’s latest piece focuses on where the top performers are in the process, and which countries and regions have a step up in the race to ‘reserve’ precious resources.
One interesting addition to this week’s chartbook is a summary of the ‘outlook’ for achieving ‘widespread vaccination’ in different parts of the world, featuring notable quotes from Dr. Fauci and Matt Hancock (the secretary of health in the UK). […]